Genfit Stock

Genfit P/B

The P/B (Price-to-Book Ratio) of Genfit (GNFT.PA) as of Aug 16, 2026 is 6.34. In the previous year, P/B (Price-to-Book Ratio) was 6.45 — a change of -1.84% (lower).

P/B

6.34

YoY

-1.84%

Last updated:

P/B (Price-to-Book Ratio) of Genfit is 2026 6.34 . P/B (Price-to-Book Ratio) of Genfit was 2025 6.45 . It decreases by -1.84% lower compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

P/B (Price-to-Book Ratio) of Genfit is 6.34 in 2026.

P/B (Price-to-Book Ratio) of Genfit changed from 6.45 to 6.34, representing a -1.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Genfit since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Genfit with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genfit

All Key Metrics — Genfit